AI-powered features like personalized playlists, Discovery Weekly, and AI DJ contributed to strong growth in premium revenue ...
Stocks to Buy and Sell. Roblox Corporation (NYSE:RBLX) is one of the top analyst calls. Kevin Simpson, Capital Wealth ...
Strong growth in daily users and top-line growth has more than doubled Roblox stock this year. The viral success of the game “Grow a Garden” contributed significantly to Roblox’s second-quarter growth ...
Goldman Sachs upgraded its rating on Roblox (RBLX) to "buy" from a previous investment rating of "neutral" on Friday.
Roblox (RBLX) reports strong quarterly results and optimistic growth potential, but cautious 2026 outlook. AI-driven tools ...
Goldman Sachs analyst Eric Sheridan upgraded Roblox to Buy with a 12-month price target of $180, implying nearly 60% upside, citing “strong platform momentum” and a clear path toward “long-term ...
On a net-income basis, Roblox is still losing considerable money. In Q3, the company had a net loss of $257 million, which was worse than its net loss of $240 million in the same quarter of last year.
InvestorsHub on MSN
Roblox Tops Bookings Forecasts and Lifts Full-Year Guidance Despite Shares Falling
Roblox Corporation (NYSE:RBLX) reported third-quarter bookings that far exceeded expectations, powered by surging user ...
Roblox shares slid after the company warned of higher losses for Q4 and 2025, overshadowing robust bookings growth.
TipRanks on MSN
Roblox Reports Strong Q3 2025 Revenue Growth
Roblox ( (RBLX) ) has provided an announcement. In its Q3 2025 report, Roblox announced a 48% year-over-year revenue growth and a 70% increase in bookings, with daily active users reaching 151.5 ...
MINNEAPOLIS — After losing back-to-back games against the Broncos and Giants, the Eagles were able to get back in the win column on Sunday afternoon with a 28-22 win over the Vikings. Jalen Hurts ...
On Thursday evening, President Donald Trump announced new efforts to expand access to IVF, which includes a deal with EMD Serono, a subsidiary of the Germany-based pharmaceutical company Merck KGaA, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results